SV

Street Verdict

Analyst Scorecard

A record of what ETMarkets Analysis said publicly, with the source. Not advice.

Pending — not yet graded
“Bullish on Biocon for the short term, with a target range of ₹403-436 in the next few weeks. The stock has broken out from a Symmetrical Triangle formation on daily charts and reclaimed crucial moving averages, indicating a bullish trend and potential for further growth.”

ETMarkets Analysis’s track record (trackable calls only): 193 graded calls · 95% CI 23–35%

BioconBullishCalled 09 Jan 2025
Verdict:PENDING

This call has no verdict yet — it is graded HIT or MISS against real price data once a close decides it. Save it above to find it again from your profile.

Read the original articleSee ETMarkets Analysis’s full track record